Assessment of Implantation Potential of Embryos by Time-lapse Technology (Embryoscope)
Embryo/Fetus Death, Blastocyst Disintegration, Aneuploidy
About this trial
This is an interventional treatment trial for Embryo/Fetus Death focused on measuring Time-lapse monitoring of embryos., Embryoscope, IVF-ET/ICSI, Cetrorelix, Gonal-F
Eligibility Criteria
Inclusion Criteria:
- Women of age 21-39 yrs.
- Basal FSH < 12mIU/ml
- Anterior mullerian hormone(AMH) > 1.0 ng/ML
- Antral follicle count (AFC) > 8
- Body mass index (BMI) < 35 mt2/kg
- Estradiol (E2) < 50PG/ML
Exclusion Criteria:
- Women with one ovary.
- Women in whom both ovaries are not seen on ultrasonography.
- Women with too small uterine cavity.
- Women with history of recurrent pregnancy loss
- Women with systemic lupus erythematosus (SLE), Nephrotic syndrome, Meyer Rocky Tansky Kustner Hammer(MRKH) syndrome,etc.
- Human immunodeficiency virus (HIV) I and II positive women.
Sites / Locations
- Lilavati Hospital and Research Center, IVF department
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Study Arm
Control Arm
Subjects would receive recombinant Follicle Stimulating Hormone (rFSH) by S.C. injection 150 - 225 IU/day for 9 days. The embryos of subjects would be cultured by time-lapse imagery technique (embryoscope) and analysis would be done using patients receive rFSH (Gonembryo viewer equipped with latest software.
Subjects would receive recombinant Follicle Stimulating Hormone (rFSH) by S.C. injection 150 - 225 IU/day for 9 days. The embryos of subjects would be cultured in conventional culture environment and analysis would be done using established subjective morphological criteria.